JP2010500331A5 - - Google Patents

Download PDF

Info

Publication number
JP2010500331A5
JP2010500331A5 JP2009523312A JP2009523312A JP2010500331A5 JP 2010500331 A5 JP2010500331 A5 JP 2010500331A5 JP 2009523312 A JP2009523312 A JP 2009523312A JP 2009523312 A JP2009523312 A JP 2009523312A JP 2010500331 A5 JP2010500331 A5 JP 2010500331A5
Authority
JP
Japan
Prior art keywords
octapeptins
residues
polymyxins
acid
natural
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009523312A
Other languages
English (en)
Japanese (ja)
Other versions
JP5226685B2 (ja
JP2010500331A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/FI2007/050441 external-priority patent/WO2008017734A1/en
Publication of JP2010500331A publication Critical patent/JP2010500331A/ja
Publication of JP2010500331A5 publication Critical patent/JP2010500331A5/ja
Application granted granted Critical
Publication of JP5226685B2 publication Critical patent/JP5226685B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009523312A 2006-08-11 2007-08-10 ポリミキシン誘導体およびその使用 Expired - Fee Related JP5226685B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US83742606P 2006-08-11 2006-08-11
US60/837,426 2006-08-11
DKPA200601055 2006-08-11
DKPA200601055 2006-08-11
PCT/FI2007/050441 WO2008017734A1 (en) 2006-08-11 2007-08-10 Polymyxin derivatives and uses thereof

Publications (3)

Publication Number Publication Date
JP2010500331A JP2010500331A (ja) 2010-01-07
JP2010500331A5 true JP2010500331A5 (enExample) 2010-08-12
JP5226685B2 JP5226685B2 (ja) 2013-07-03

Family

ID=39032653

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009523312A Expired - Fee Related JP5226685B2 (ja) 2006-08-11 2007-08-10 ポリミキシン誘導体およびその使用

Country Status (21)

Country Link
EP (2) EP3078672A1 (enExample)
JP (1) JP5226685B2 (enExample)
KR (2) KR101502453B1 (enExample)
CN (2) CN103059106B (enExample)
AU (1) AU2007283514B2 (enExample)
BR (1) BRPI0715095B8 (enExample)
CA (1) CA2694289C (enExample)
CY (1) CY1117848T1 (enExample)
DK (1) DK2057185T3 (enExample)
ES (1) ES2575521T3 (enExample)
HR (1) HRP20160552T1 (enExample)
HU (1) HUE028271T2 (enExample)
IL (2) IL196693B (enExample)
MX (1) MX2009001398A (enExample)
NO (1) NO341982B1 (enExample)
NZ (1) NZ575421A (enExample)
PL (1) PL2057185T3 (enExample)
PT (1) PT2057185E (enExample)
RU (1) RU2455311C2 (enExample)
SI (1) SI2057185T1 (enExample)
WO (1) WO2008017734A1 (enExample)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060004185A1 (en) 2004-07-01 2006-01-05 Leese Richard A Peptide antibiotics and peptide intermediates for their prepartion
FI20085469A0 (fi) * 2008-02-08 2008-05-16 Northern Antibiotics Oy Polymyksiinijohdannaiset, joissa on lyhyt rasvahappohäntä, ja niiden käyttöjä
CA2747995A1 (en) 2008-12-23 2010-07-01 Biosource Pharm, Inc. Antibiotic compositions for the treatment of gram negative infections
US8415307B1 (en) 2010-06-23 2013-04-09 Biosource Pharm, Inc. Antibiotic compositions for the treatment of gram negative infections
WO2012051663A1 (en) * 2010-10-21 2012-04-26 Monash University Antimicrobial compounds
CN103946233A (zh) * 2011-11-18 2014-07-23 诺瓦克塔生物系统有限公司 多黏菌素衍生物
RU2730012C2 (ru) * 2013-05-22 2020-08-14 Сперо Терапьютикс, Инк. Производные полимиксина и их применение в комбинированной терапии совместно с различными антибиотиками
HRP20220387T1 (hr) * 2014-03-11 2022-05-27 Spero Therapeutics, Inc. Derivati polimiksina i njihova upotreba u kombinacijskoj terapiji zajedno s različitim antibioticima
KR101664106B1 (ko) 2014-09-11 2016-10-10 한국화학연구원 폴리믹신 b 화합물을 포함하는 심혈관 질환의 예방 및 치료용 약학적 조성물
CN107108699A (zh) * 2014-11-26 2017-08-29 新药物许可控股有限公司 化合物
WO2016100578A2 (en) 2014-12-16 2016-06-23 Micurx Pharmaceuticals, Inc. Antimicrobial polymyxins for treatment of bacterial infections
DK3233105T3 (da) * 2014-12-18 2020-11-16 Helperby Therapeutics Ltd Hidtil ukendt kombination og anvendelse
FI126143B (en) * 2015-01-15 2016-07-15 Northern Antibiotics Oy Polymyxine derivative and its uses
US9763996B2 (en) 2015-01-16 2017-09-19 Northern Antibiotics, Ltd. Polymyxin derivative and uses thereof
CN104672307B (zh) * 2015-03-23 2017-09-29 吉林大学 一种提高阳离子短肽抗菌性和稳定性的方法
EP3072956A1 (en) * 2015-03-25 2016-09-28 Université de Fribourg Selective culture medium for polymyxin-resistant, gram-negative bacteria
FR3036406B1 (fr) 2015-05-20 2019-07-19 Biomerieux Identification des bacteries resistantes aux carbapenemes par impermeabilite membranaire
JP2018534303A (ja) 2015-11-12 2018-11-22 ザ・トラスティーズ・オブ・コロンビア・ユニバーシティ・イン・ザ・シティ・オブ・ニューヨーク ポリミキシン系抗生物質に対する耐性グラム陰性細菌感染を標的にする合理的薬物設計
WO2017189868A1 (en) * 2016-04-27 2017-11-02 Spero Opco Serine replacement polymyxin analogues useful as antibiotic potentiators
WO2017189866A1 (en) * 2016-04-27 2017-11-02 Spero Opco Polymyxin analogs useful as antibiotic potentiators
GB201703898D0 (en) 2017-03-10 2017-04-26 Helperby Therapeautics Ltd Method
GB201704620D0 (en) 2017-03-23 2017-05-10 Helperby Therapeautics Ltd Combinations
US11279733B2 (en) * 2017-11-02 2022-03-22 The University Of Queensland Peptide antibiotics
EP3560489A1 (en) * 2018-04-27 2019-10-30 European Molecular Biology Laboratory Pharmaceutical compositions for prevention and/or treatment of infections and antibacterial-induced dysfunctions
HRP20240028T1 (hr) 2018-06-25 2024-03-29 Spero Therapeutics, Inc. Spojevi
JP7469812B2 (ja) * 2018-07-19 2024-04-17 ノースイースタン ユニバーシティ 抗微生物特性を有する化合物
CN110179967A (zh) * 2019-05-28 2019-08-30 中国医药集团总公司四川抗菌素工业研究所 多粘菌素母核和一种抗生素的组合物及其应用
IT201900025414A1 (it) 2019-12-23 2021-06-23 Univ Bologna Alma Mater Studiorum Composto per il trattamento della sindrome emolitico uremica
WO2021150792A1 (en) 2020-01-21 2021-07-29 Micurx Pharmaceuticals, Inc. Novel compounds and composition for targeted therapy of kidney-associated cancers
CN118028503B (zh) * 2022-08-30 2024-08-09 四川大学华西医院 一类phoQ基因突变体、应用及其验证方法
WO2024123712A1 (en) * 2022-12-04 2024-06-13 Genentech, Inc. Analysis of candidate cytotoxic compositions
CN120399010B (zh) * 2025-07-01 2025-09-12 杭州肽佳生物科技有限公司 抗生素多粘菌素的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3450687A (en) 1966-02-24 1969-06-17 Pfizer & Co C Lower alkanoyl esters of polymyxin antibiotics
JPS4915537B1 (enExample) 1970-03-25 1974-04-16
BE754411A (fr) 1969-08-05 1971-02-04 Rhone Poulenc Sa Cyclopeptides derives des polymyxines et leur
GB2128617A (en) 1982-10-06 1984-05-02 Martti Vaara Polypeptides for use in antibacterial therapy
MXPA03004437A (es) * 2000-11-20 2004-05-04 Daiichi Seiyaku Co Compuestos de deshalogeno.
WO2002055543A2 (en) 2001-01-16 2002-07-18 Univ Ramot Hybrid peptides for treatment of bacteremia and septicemia
ATE349223T1 (de) * 2002-03-01 2007-01-15 Chiesi Farma Spa Pharmazeutische zubereitungen mit verbesserten oberflächeneigenschaften welche ein lungen surfactant und ein polymyxin enthalten
US20060004185A1 (en) * 2004-07-01 2006-01-05 Leese Richard A Peptide antibiotics and peptide intermediates for their prepartion

Similar Documents

Publication Publication Date Title
JP2010500331A5 (enExample)
CY1113858T1 (el) Παραγωγα πυριδιν-3-υλιου ως ανοσορυθμιστικοι παραγοντες
WO2010033444A8 (en) Crystalline forms of a 2-thiazolyl- 4-quinolinyl-oxy derivative, a potent hcv inhibitor
JP2010525017A5 (enExample)
JP2009535462A5 (enExample)
MA32812B1 (fr) Composition pharmaceutique d'un inhibiteur puissant du vhc pour une administration orale
CL2007001131A1 (es) Compuestos derivados de purina sustituida; proceso de preparacion; composicion farmaceutica; y uso en el tratamiento de una enfermedad inflamatoria u obstructiva de las vias respiratorias.
CL2007001132A1 (es) Compuestos derivados de purina sustituida con otros sistemas heterociclicos; proceso de preparacion; composicion farmaceutica; y uso en el tratamiento de una enfermedad inflamatoria u obstructiva de las vias respiratorias.
NO20080129L (no) Fremgangsmate for fremstilling av dihydrokinazoliner
JP2006517944A5 (enExample)
JP2007522094A5 (enExample)
WO2009066315A3 (en) Sustained release compositions of trimetazidine and process for preparation thereof
ZA200706306B (en) Diketo acids with nucleobase scaffolds: anti-HIV replication inhibitors targeted at HIV integrase
CL2007003519A1 (es) Compuestos derivados de quinolina sustituida; proceso de preparacion; compuesto intermediario; composicion farmaceutica; combinacion farmaceutica; y uso en el tratamiento de una infeccion bacteriana.
MA31445B1 (fr) Composition à libération modifiée comprenant un dérivé de somatostatine en microparticules
CY1114364T1 (el) Φαρμακευτικες συνθεσεις για την θεραπεια της αρτηριοπαθειας των τριχοειδων αγγειων
WO2008104852A3 (en) Pharmaceutical compositions comprising adsorbate of fenofibrate
JP2008515980A5 (enExample)
JP2009540203A5 (enExample)
TW200503703A (en) Pharmaceutical compositions
JP2010518075A5 (enExample)
JP2008523232A5 (enExample)
JP2011012060A5 (enExample)
JP2007217514A5 (enExample)
CL2007003518A1 (es) Compuestos derivados de quinolina sustituida; proceso de preparacion; compuesto intermediario; composicion farmaceutica; combinacion farmaceutica; y uso en el tratamiento de una infeccion bacteriana.